PTK7/β-catenin-IN-2 (compound 04967) acts as an inhibitor targeting both PTK7 and β-catenin, effectively preventing their interaction with an IC50 of 5.6 μM and disrupting the Wnt/β-catenin signaling pathway. This interference supports its role in inhibiting cell growth reliant on Wnt signaling, exhibiting anticancer capabilities. Additionally, the compound displays an inhibitory effect on the binding of p53 to MDM2, with an IC50 value of 157.1 μM [1].
Marketplace OffersShowing from 3 suppliers
Supplier
TargetMolSC
Pack Size
Estimated Lead Time
10-14 weeks
Purity
-
Inquiry
1
Supplier
ChemDivSC
Pack Size
Estimated Lead Time
3-5 weeks
Purity
-
$ 148.00
1
Supplier
Alinda ChemicalSC
Pack Size
Estimated Lead Time
4-6 weeks
Purity
-
$ 165.00
1
You cannot determine which compound library is the best fit for your project? Do you need a custom solution? AnyMol is always ready to help you.